Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yolanda, McKinney"'
Autor:
Kilian E. Salerno, Baris Turkbey, Liza Lindenberg, Esther Mena, Erica E. Schott, Alexandra K. Brennan, Soumyajit Roy, Uma Shankavaram, Krishnan Patel, Theresa Cooley-Zgela, Yolanda McKinney, Bradford J. Wood, Peter A. Pinto, Peter Choyke, Deborah E. Citrin
Publikováno v:
Brachytherapy
PURPOSE/OBJECTIVE(S): This study describes the pattern of failure in patients with biochemical (BCR) recurrence after low-dose-rate (LDR) brachytherapy as a component of definitive treatment for prostate cancer. METHODS: Patients with BCR after LDR b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c73c026fda46ab2fafdb4c80d3fa75b8
https://doi.org/10.1016/j.brachy.2022.03.009
https://doi.org/10.1016/j.brachy.2022.03.009
Autor:
Peter A. Pinto, Baris Turkbey, Sarah E Reese, Peter L. Choyke, Stephanie Harmon, Ilhan Lim, Yolanda McKinney, Anita Ton, Philip Eclarinal, Janet F. Eary, Venkatesh Krishnasamy, Ravi A. Madan, Deborah Citrin, Frank I. Lin, Elliot Levy, Joanna H. Shih, Bradford J. Wood, Richard Chang, Liza Lindenberg, William L. Dahut, Esther Mena
Publikováno v:
Radiology. 296:564-572
Background Prostate cancer recurrence is found in up to 40% of men with prior definitive (total prostatectomy or whole-prostate radiation) treatment. Prostate-specific membrane antigen PET agents such as 2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine 3-c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd8b0ddb9d02ad278342f875e51497b7
https://doi.org/10.1148/radiol.2020192018
https://doi.org/10.1148/radiol.2020192018
Autor:
Anna Couvillon, Baris Turkbey, Peter L. Choyke, Katherine Lee-Wisdom, Yolanda McKinney, Robert Sidlow, Michael P. Mullane, Veda N. Giri, Todd Matthew Morgan, Heather H. Cheng, Maria J. Merino, William Douglas Figg, Peter A. Pinto, William L. Dahut, Fatima Karzai
Publikováno v:
Journal of Clinical Oncology. 41:390-390
390 Background: PCa has inherited risk factors including high genetic risk variants such as BRCA1/2, HOXB13, and DNA mismatch repair genes. mpMRI has been shown to be effective for detection and staging of localized PCa. This study follows participan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c16d402381723be3c38899fe933dd67
https://doi.org/10.1200/jco.2023.41.6_suppl.390
https://doi.org/10.1200/jco.2023.41.6_suppl.390
Autor:
Michelle, Lu, Liza, Lindenberg, Esther, Mena, Baris, Turkbey, Jurgen, Seidel, Anita, Ton, Yolanda, McKinney, Philip, Eclarinal, Maria, Merino, Peter, Pinto, Peter, Choyke, Stephen, Adler
Publikováno v:
Molecular imaging and biology. 24(3)
The primary aim of this study was to investigate the pharmacokinetics ofTen consecutive patients with biopsy-proven high-risk prostate cancer underwent a dynamicHigh-risk primary prostate cancer is readily identified on dynamic and static, delayed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c55000bfc94083be0db1655fd1f8209
https://pubmed.ncbi.nlm.nih.gov/34724140
https://pubmed.ncbi.nlm.nih.gov/34724140
Autor:
Peter L. Choyke, Peter A. Pinto, Yolanda McKinney, Inger L. Rosner, Isabell A. Sesterhenn, Shiv Srivastava, Bradford J. Wood, Albert Dobi, Denise Young, Jennifer Cullen, William Gesztes, Thomas Sanford, Jonathan Sackett, Baris Turkbey, Stephanie Harmon, Maria Merino, Sherif Mehralivand
Publikováno v:
Radiology
BACKGROUND: Although prostate MRI is routinely used for the detection and staging of localized prostate cancer, imaging-based assessment and targeted molecular sampling for risk stratification are an active area of research. PURPOSE: To evaluate feat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187f06f354ba43f09aa8dc5c7120ea92
https://europepmc.org/articles/PMC8165944/
https://europepmc.org/articles/PMC8165944/
Autor:
William D. Figg, Elliot Levy, Billel Gasmi, Baris Turkbey, Tristan M. Sissung, Lisa M. Cordes, Peter L. Choyke, Maria Merino, Cindy H. Chau, Yolanda McKinney, Jonathan D. Strope, Douglas K. Price, Keith T. Schmidt, Peter A. Pinto, Joanna H. Shih, Bradford J. Wood, Sarah E Lochrin, Suzana Markolovic, Ravi A. Madan, William L. Dahut
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports
Scientific Reports
OATP1B3 is expressed de novo in primary prostate cancer tissue and to a greater degree in prostate cancer metastases. Gadoxetate disodium is a substrate of OATP1B3, and its uptake has been shown to correlate with OATP1B3 expression in other cancers.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6377a658cadacc5b8827af5949c0ab18
https://doi.org/10.1038/s41598-021-84960-w
https://doi.org/10.1038/s41598-021-84960-w
Autor:
Philip Eclarinal, Yolanda McKinney, Maria Liza Lindenberg, Janet F. Eary, Venkatesh Krishnasamy, Ismael Baris Turkbey, Esther Mena, Bradford J. Wood, Ilhan Lim, Stephen Adler, Stephanie Harmon, Richard Chang, Elliot Levy, Peter L. Choyke, Maria J. Merino, William L. Dahut, Joanna H. Shih, Peter A. Pinto, Deborah Citrin, Frank I. Lin
Publikováno v:
J Nucl Med
Our objective was to investigate the lesion detection rate of (18)F-DCFPyL PET/CT, a prostate-specific membrane antigen (PSMA)–targeted PET agent, in patients with biochemically relapsed prostate cancer after primary local therapy. Methods: This wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40083c7f2392fb0a7b9c19f231d1fdf1
https://europepmc.org/articles/PMC9374042/
https://europepmc.org/articles/PMC9374042/
Autor:
Stephen Adler, Yolanda McKinney, Joanna H. Shih, Esther Mena, Anna Couvillon, Liza Lindenberg, Baris Turkbey, Martin G. Pomper, Peter L. Choyke, William L. Dahut, Ravi A. Madan, Ronnie C. Mease, Ethan Bergvall, James L. Gulley, Adam G. Sowalsky, Sherif Mehralivand, Janet F. Eary, Stephanie Harmon
Publikováno v:
Oncotarget. 9:37676-37688
// Stephanie A. Harmon 1, 2 , Esther Mena 2 , Joanna H. Shih 3 , Stephen Adler 1, 2 , Yolanda McKinney 2 , Ethan Bergvall 2 , Sherif Mehralivand 2 , Adam G. Sowalsky 4 , Anna Couvillon 5 , Ravi A. Madan 5 , James L. Gulley 5 , Janet Eary 6 , Ronnie C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3e3d0e6473830bbe453db46f2c0ebd1
https://doi.org/10.18632/oncotarget.26481
https://doi.org/10.18632/oncotarget.26481
Autor:
Deborah Citrin, Ethan Bergvall, Paula M. Jacobs, Yolanda McKinney, Stephanie Harmon, James L. Gulley, Peter L. Choyke, Baris Turkbey, Sherif Mehralivand, Ravi A. Madan, Martin G. Pomper, Stephen Adler, Joanna H. Shih, M. Liza Lindenberg, Anna Couvillon, Esther Mena, Ronnie C. Mease
Publikováno v:
Journal of Nuclear Medicine. 59:1665-1671
The purpose of this study was to compare the diagnostic performance of 18F-DCFBC PET/CT, a first-generation 18F-labeled prostate-specific membrane antigen (PSMA)-targeted agent, and 18F-NaF PET/CT, a sensitive marker of osteoblastic activity, in a pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8312aaa975f9ea8cbdd0cdecfa5f88d0
https://doi.org/10.2967/jnumed.117.207373
https://doi.org/10.2967/jnumed.117.207373
Autor:
Peter A. Pinto, Maria J. Merino, William L. Dahut, Heather H. Cheng, Anna Couvillon, Veda N. Giri, Fatima Karzai, Yolanda McKinney, Baris Turkbey, Peter L. Choyke, Katherine Lee-Wisdom, Todd M. Morgan
Publikováno v:
Cancer Research. 81:2605-2605
Introduction: The understanding of molecular genetics in PCa provides insight into disease progression and treatment. Less is known about PCa development in men with known high-risk germline pathogenic/likely pathogenic variants in PCa related genes,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf668df1d99977ccd86626b693f70f8b
https://doi.org/10.1158/1538-7445.am2021-2605
https://doi.org/10.1158/1538-7445.am2021-2605